Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
15β-Hydroxycyproterone acetate
Подписчиков: 0, рейтинг: 0
Clinical data | |
---|---|
Other names | 15β-Hydroxy-CPA; 15β-OH-CPA; 6-Chloro-15β,17α-dihydroxy-1α,2α-methylenepregna-4,6-diene-3,20-dione 17α-acetate; 6-Chloro-1,2α-methylene-15β,17α-dihydroxy-δ6-progesterone 17α-acetate |
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C24H29ClO5 |
Molar mass | 432.94 g·mol−1 |
3D model (JSmol) | |
| |
|
15β-Hydroxycyproterone acetate (15β-OH-CPA) is a steroidal antiandrogen and the major metabolite of cyproterone acetate (CPA). It is formed from CPA in the liver by hydroxylation via the cytochrome P450 enzyme CYP3A4. During therapy with CPA, 15β-OH-CPA circulates at concentrations that are approximately twice those of CPA. 15β-OH-CPA has similar or even greater antiandrogen activity compared to CPA. However, it has only about one-tenth of the activity of CPA as a progestogen. 15β-OH-CPA also shows some glucocorticoid activity, similarly to CPA and unesterified cyproterone.
See also
Topics | |
---|---|
Metabolites |
|
Combinations | |
Related drugs |
|
GR |
|
||||||||
---|---|---|---|---|---|---|---|---|---|
PR |
|
||||||
---|---|---|---|---|---|---|---|
mPR (PAQR) |
|
||||||